Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Divi's Laboratories Ltd.
NSE: DIVISLAB
|
BSE: 532488
|
ISIN: INE361B01024
|
Industry: Pharmaceuticals
|
Expensive Performer
6092.5000
-107.50
(
-1.73
%)
NSE
Sep 22, 2025
15:31 PM
Volume:
290.6K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Divi's Laboratories Ltd.
10 Feb 2024
6092.50
-1.73%
Divi's Labs (SELL): Healthy margin recovery, heady valuations
Sell:
Divi's Laboratories Ltd.
by
BOB Capital Markets Ltd.
Target: 3000
Recommendation
Target
BOB Capital Markets Ltd.
Q3 revenue grew 9% YoY on 25% rise in custom synthesis business; API and nutraceuticals stayed soft
Divi's Laboratories .. has an
average target
of 6414.33 from 6 brokers.
More from Divi's Laboratories Ltd.
Recommended
IPO market heats up: 29 new offerings and 8 listings this week
|
22 Sep 2025, 05:34PM
Market closes lower, Brigade Enterprises gets Rs 126 cr investment from Manipal Group
Trendlyne Marketwatch |
22 Sep 2025, 03:58PM
Custom synthesis business drives growth for Divi’s Laboratories
|
10 Mar 2022